GlassScriptPhysician profile
Khanh Hoang
NPI 1396421848
$10,797.81
in general payments reported to CMS, 2019-2025
18 companies · $8,790 in 2025
The $8,790 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $464 · 2024: $1,544 · 2025: $8,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,904 · Consulting Fee: $3,300 · Travel and Lodging: $1,341 · Entertainment: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,904.27 |
| Consulting Fee | $3,300.00 |
| Travel and Lodging | $1,341.36 |
| Entertainment | $252.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $6,731.34 | 2024-2025 | Travoprost Intraocular Implant - Idose, Idosetr, Kxl System (Not Refurbished) |
| Biotissue Holdings INC. | $766.30 | 2025 | |
| Alcon Vision LLC | $510.63 | 2024-2025 | Tryptyr, Rhopressa, Rocklatan |
| Abbvie INC. | $456.21 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $371.67 | 2023-2025 | Vyzulta, Infuse, Miebo |
| Harrow Eye, LLC | $348.09 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $331.60 | 2024-2025 | |
| Optos, INC. | $252.18 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $217.22 | 2023-2025 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $198.55 | 2024-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $114.06 | 2023-2025 | Acuvue |
| Coopervision INC. | $111.49 | 2025 | Clariti Contact Lens |
| Sight Sciences, INC. | $98.11 | 2024-2025 | Tearcare System, Omni Surgical System |
| Amgen INC. | $90.42 | 2024 | Tepezza |
| Rxsight INC | $90.06 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $61.28 | 2024 | Tecnis Simplicity |
| Tarsus Pharmaceuticals, INC. | $29.27 | 2025 | Xdemvy |
| Thea Pharma INC. | $19.33 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khanh Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.